XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.4
Fair Value Measurements (Tables)
 3 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Summary of Financial Assets and Liabilities Measured at Fair Value
The following tables summarize the Company’s financial assets and liabilities measured at fair value in the accompanying unaudited condensed consolidated balance sheets as of December 31, 2024 and September 30, 2024:
December 31, 2024
($ in thousands)Level 1Level 2Level 3Total
Assets: 
Investment in Equity Securities$135 $— $— $135 
Derivative and hedging instruments— 5,223 — 5,223 
Liabilities: 
Contingent Consideration— — 14,947 14,947 
September 30, 2024
($ in thousands)Level 1Level 2Level 3Total
Assets:    
Investment in Equity Securities$128 $— $— $128 
Derivative and hedging instruments— 1,560 — 1,560 
Liabilities:    
Contingent Consideration— — 15,161 15,161 
Derivative and hedging instruments— 3,626 — 3,626 
Summary of Unrealized Gains (Losses) Recognized Related to Equity Securities
The portion of unrealized losses (gains) recognized related to equity securities still held as of December 31, 2024 and 2023 consists of the following:
($ in thousands)Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Net (gain) loss recognized during the period on equity securities$(7)$112 
Less net loss recognized during the period on equity securities sold during the period— — 
Unrealized (gain) loss recognized during the reporting period on equity securities still held at the reporting date$(7)$112 
Summary of Changes in Fair Value of Contingent Consideration
The following table sets forth the changes in fair value of our contingent consideration for the three months ended December 31, 2024:
($ in thousands)Three Months Ended December 31, 2024
Balance as of September 30, 2024$15,161 
Additions from acquisitions— 
Settlement of contingent consideration(456)
Change in fair value, including accretion242 
Balance as of December 31, 2024$14,947